Models of chemotherapy drug-induced peripheral neuropathy

Drug Discovery Today: Disease Models

Volumn 1, Issue 2, 2004, Pages 186-191

  Golden, Judith P ^a   Johnson Jr , Eugene M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PACLITAXEL; VINCRISTINE;

CHEMOTHERAPY; DISEASE MODEL; DRUG INDUCED DISEASE; DRUG TOLERABILITY; EXPERIMENTAL MODEL; IN VITRO STUDY; IN VIVO STUDY; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NEUROPATHY; REVIEW;

EID: 23744441532     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2004.09.005     Document Type: Review

References (38)

1. Quasthoff, S. and Hartung, H.P. (2002) Chemotherapy-induced peripheral neuropathy. J. Neurol. 249, 9-17
2. Dina, O.A. et al. (2001) Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience 108, 507-515
3. Polomano, R.C. et al. (2001) A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94, 293-304
4. Smith, S.B. et al. (2004) Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains. Life Sci. 74, 2593-2604
5. Dina, O.A. et al. (2004) Integrin signaling in inflammatory and neuropathic pain in the rat. Eur. J. Neurosci. 19, 634-642
6. Alessandri-Haber, N. et al. (2004) Transient receptor potential Vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat. J. Neurosci. 24, 4444-4452
7. Flatters, S.J.L. and Bennett, G.J. (2004) Ethosuximide reverses paclitaxel-and vincristine-induced painful peripheral neuropathy. Pain 109, 150-161
8. Authier, N. et al. (2000) Description of a short-term taxol-induced nociceptive neuropathy in rats. Brain Res. 887, 239-249
9. Boyle, F.M. et al. (1999) Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J. Neuro-Oncol. 41, 107-116
10. Cavaletti, G. et al. (1995) Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp. Neurol. 133, 64-72
11. Kilpatrick, T.J. et al. (2001) Leukaemia inhibitory factor abrogates paclitaxel-induced axonal atrophy in the Wistar rat. Brain Res. 911, 163-167
12. Bardos, G. et al. (2003) BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats. Toxicol. Appl. Pharmacol. 190, 9-16
13. Lipton, R.B. et al. (1989) Taxol produces a predominantly sensory neuropathy. Neurology 39, 368-373
14. Authier, N. et al. (2000) Assessment of allodynia and hyperalgesia after cisplatin administration to rats. Neurosci. Lett. 291, 73-76
15. Authier, N. et al. (2003) An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp. Neurol. 182, 12-20
16. Chattopadhyay, M. et al. (2004) Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy. Brain 127, 929-939
17. Aloe, L. et al. (2000) Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis. Auton. Neurosci. 86, 84-93
18. Pisano, C. et al. (2003) Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin. Cancer Res. 9, 5756-5767
19. Joseph, E.K. and Levine, J.D. (2003) Sexual dimorphism for protein kinase c epsilon signaling in a rat model of vincristine-induced painful peripheral neuropathy. Neuroscience 119, 831-838
20. Authier, N. et al. (2003) A new animal model of vincristine-induced nociceptive peripheral neuropathy. Neurotoxicology 24, 797-805
21. Aley, K.O. et al. (1996) Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience 73, 259-265
22. Authier, N. et al. (1999) Pain related behaviour during vincristine-induced neuropathy in rats. Neuroreport 10, 965-968
23. Nozaki-Taguchi, N. et al. (2001) Vincristine-induced allodynia in the rat. Pain 93, 69-76
24. Verstappen, C.C. et al. (2003) Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63, 1549-1563
25. Postma, T.J. et al. (1993) Long-term effects of vincristine on the peripheral nervous system. J. Neuro-Oncol. 15, 23-27
26. Legha, S.S. (1986) Vincristine neurotoxicity. Pathophysiology and management. Med. Toxicol. 1, 421-427
27. Casey, E.B. et al. (1973) Vincristine neuropathy. Clinical and electrophysiological observations. Brain 96, 69-86
28. Lin, C.R. et al. (2002) Effect of thiopental, propofol, and etomidate on vincristine toxicity in PC12 cells. Cell Biol. Toxicol. 18, 63-70
29. Nicolini, G. et al. (2003) Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem. Int. 42, 419-429
30. Ozturk, G. et al. (2004) The effect of Ginkgo extract EGb761 in cisplatin-induced peripheral neuropathy in mice. Toxicol. Appl. Pharmacol. 196, 169-175
31. Park, S.A. et al. (2000) Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J. Neurochem. 75, 946-953
32. Sano, M. (2001) Radicicol and geldanamycin prevent neurotoxic effects of anti-cancer drugs on cultured embryonic sensory neurons. Neuropharmacology 40, 947-953
33. Hayakawa, K. et al. (1998) NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants. Brain Res. 794, 313-319
34. Marchand, F. et al. (2003) Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat. Brain Res. 980, 117 -120
35. Tanner, K.D. et al. (1998) Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. J. Neurosci. 18, 6480-6491
36. Tanner, K.D. et al. (2003) Altered temporal pattern of evoked afferent activity in a rat model of vincristine-induced painful peripheral neuropathy. Neuroscience 118, 809-817
37. Weng, H.R. et al. (2003) Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 103, 131-138
38. Tanner, K.D. et al. (1998) Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J. Comp. Neurol. 395, 481-492